Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development

Pediatric Research

Volumn 43, Issue 2, 1998, Pages 163-168

  Sanchez, Lucienne S ^a   De La Monte, Suzanne M ^a   Filippov, Galina ^a   Jones, Rosemary C ^a   Zapol, Warren M ^a   Bloch, Kenneth D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE INHIBITOR; ZAPRINAST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DEVELOPMENTAL GENETICS; ENZYME ACTIVITY; FETUS; GENE EXPRESSION REGULATION; HYDROLYSIS; LUNG BLOOD VESSEL; LUNG DEVELOPMENT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0031951754     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199802000-00002     Document Type: Article

References (40)

1. Abman SH, Chatfield BA, Hall SL, McMurtry IF 1990 Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 259:H1921-H1927
2. Cornfield DN, Chatfield BA, McQueston JA, McMurtry IF, Abman SH 1992 Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus. Am J Physiol 262:H1474-H1481
3. Davidson D, Eldermerdash S 1990 Endothelium-derived relaxing factor: presence in pulmonary and systemic arteries of the newborn guinea pig. Pediatr Res 27:128-132
4. Moore P, Velvis H, Fineman JR, Soifer SJ, Heyman MA 1992 EDRF inhibition attenuates the increase in pulmonary blood flow due to oxygen ventilation of fetal lambs. J Appl Physiol 73:2151-2157
5. Roberts JD, Chen TY, Kawai N, Wain J, Dupuy P, Shimouchi A, Bloch KD, Polaner D, Zapol WM 1993 Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res 72:246-254
6. Tiktinsky MH, Cummings JJ, Morin FC 1992 Acetylcholine increases pulmonary blood flow in intact fetuses via endothelium-dependent vasodilation. Am J Physiol 262:H406-H410
7. McAllister-Lucas LM, Sonnenburg WK, Kadlecek A, Seger D, Trong HL, Colbran JL, Thomas MK, Walsh KA, Francis SH, Corbin JD, Beavo JA 1993 The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase from a cDNA clone. J Biol Chem 268:22863-22873
8. Beavo JA, Reifsnyder DH 1990 Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 11:150-155
9. Beavo JA, Conti M, Heaslip RJ 1994 Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 46:399-405
10. Dent G, Magnussen H, Rabe KF 1994 Cyclic nucleotide phosphodiesterases in the human lung. Lung 172:129-146
11. Thomas MK, Francis SH, Corbin JD 1990 Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase. J Biol Chem 265:14964-14970
12. Ahn HS, Foster M, Cable M, Pitts BJR, Sybertz EJ 1991 Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues. Adv Exp Med Biol 308:191-197
13. Pyne NJ, Burns F 1993 Lung phosphodiesterase isoenzymes. Agents Actions Suppl 43:35-49
14. McMahon TJ, Ignarro LJ, Kadowitz PJ 1993 Influence of zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. J Appl Physiol 74-1704-1711
15. Ichinose F, Hurford WE, Zapol WM 1995 Selective pulmonary vasodilation by inhaled nitric oxide (NO) and nebulized zaprinast in awake lambs. Am J Respir Crit Care Med 151:A730
16. Ichinose F, Adrie C, Hurford WE, Zapol WM 1995 Prolonged pulmonary vasodilator action of inhaled nitric oxide by zaprinast, in awake lambs. J Appl Physiol 78:1288-1295
17. Kawai N, Bloch DB, Filippov G, Rabkina D, Suen H-C, Losty PD, Janssens SP, Zapol WM, de la Monte SM, Bloch KD 1995 Constitutive endothelial nitric oxide synthase gene expression is regulated during lung development. Am J Physiol 268:L589-L595
18. North AJ, Star RA, Brannon TS, Ujiie K, Wells LB, Lowenstein CJ, Snyder SH, Shaul PW 1994 Nitric oxide synthase type I and type III gene expression are developmentally regulated in rat lung. Am J Physiol 266:L635-L641
19. Bloch KD, Filippov G, Sanchez LS, Nakane M, de la Monte SM 1997 Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period. Am J Physiol 272:L400-L406
20. Sambrook J, Fritsh EF, Maniatis T 1989 Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp 7.19-7.22
21. Francis SH, Corbin JD 1988 Purification of cGMP-binding protein phosphodiesterase from rat lung. Methods Enzymol 159:722-729
22. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
23. Beltman J, Becker DE, Butt E, Jensen GS, Rybalkin SD, Jastorff B, Beavo JA 1995 Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains. Mol Pharmacol 47:330-339
24. Ahn HS, Crim W, Romano M, Sybertz E, Pitts B 1989 Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta. Biochem Pharmacol 38:3331-3339
25. Ahn HS, Crim W, Pitts B, Sybertz EJ 1992 Calcium-calmodulin-stimulated and cGMP-specific phosphodiesterases. Adv Second Messenger Phosphoprotein Res 25:271-288
26. Torphy TJ, Undem BJ, Cieslinski LB, Luttmann MA, Reeves ML, Hay DWP 1993 Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J Pharmacol Exp Ther 265:1213-1223
27. Wong SK-F, Garbers DL 1992 Receptor guanylyl cyclases. J Clin Invest 90:299-305
28. Burri PH 1985 Development and growth of the human lung. In: Fishman AP, Fisher AB, Geiger SR (eds) Handbook of Physiology, Section 3: The Respiratory System. American Physiological Society, Bethesda, MD, pp 1-46
29. Meyrick B, Reid L 1982 Pulmonary arterial and alveolar development in normal postnatal rat lung. Am Rev Respir Dis 125:468-473
30. Haworth SG 1988 Pulmonary vascular remodeling in neonatal pulmonary hypertension. State of the art. Chest 93(suppl):133S-138S
31. Trachtman H, Futterweit S, Singhal P 1995 Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun 207:120-125
32. Kolpakov V, Gordon D, Kulik TJ 1995 Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 76:305-309
33. Garg UC, Hassid A 1989 Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat smooth muscle cells. J Clin Invest 83:1774-1777
34. Dubey RK, Jackson EK, Luscher TF 1995 Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cells: role of cyclic-nucleotides and angiotensin 1 receptors. J Clin Invest 96:141-149
35. Pollman M, Yamada T, Horiuchi M, Gibbons GH 1995 Interaction of nitric oxide and angiotensin II modulates vascular smooth muscle programmed cell death. FASEB J 9:A314
36. Roberts JD, Fineman JR, Morin FC, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol WM 1997 Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The inhaled nitric oxide study group. N Engl J Med 336:605-610
37. Group TNINOS 1997 Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 336:597-604
38. Sanchez LS, Short BL 1990 Extracorporeal membrane oxygenation (ECMO) in neonatal cardiopulmonary failure. Respiratory Management 20:135-139
39. Braner DAV, Fineman JR, Chang R, Soifer SJ 1993 M & B 22948, a cGMP phosphodiesterase inhibitor, is a pulmonary vasodilator in lambs. Am J Physiol 264:H252-H258
40. Thusu KG, Morin FC, Russell JA, Steinhorn RH 1995 The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am J Respir Crit Care Med 152:1605-1610